Pascal Edrich - Concepedia

Author

Pascal Edrich

UCB Pharma (Belgium)

Also Known As

G. Shah, P. Edrich, Pascal Edrich

Publications

549

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)Roche (Switzerland)

About

Pascal Edrich is an author at UCB Pharma (Belgium) specializing in medicine, pharmacotherapy, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	233
2	Neurology	5	5	195
3	Social Sciences	2	2	38
4	Health Sciences	1	1	38
5	Molecular Medicine	1	1	38

Pascal Edrich

Publications

341

Citations

H-Index

Page 1

	Year	Citations
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy Elinor Ben‐Menachem, Pascal Edrich, Betty Van Vleymen, Epilepsy Research Sustained EfficacyMedicinePsychotropic MedicationPsychopharmacologyNeuropharmacology	2003	79
Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study Jing‐Jane Tsai, Der‐Jen Yen, Mo‐Song Hsih, Epilepsia	2006	72
Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies William E. Rosenfeld, Selim R. Benbadis, Pascal Edrich, Epilepsy Research Psychotropic MedicationPediatricsPlacebo-controlled StudiesNeuropharmacologyNeurology	2009	56
Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd beyond one year. Richard A. Larson, Phillipp D. Le Coutre, Josy Reiffers, Journal of Clinical Oncology PharmacotherapyMyeloid NeoplasiaChronic PhaseHematological MalignancyNilotinib 300	2010	38
Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study Patrick Kwan, Shih Hui Lim, Yotin Chinvarun, Epilepsy & Behavior Adjunctive TherapyUncontrolled Partial EpilepsyPsychiatryPsychotropic MedicationAdult Patients	2010	22
Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience Ilo E. Leppik, Katrien De Rue, Pascal Edrich, Epileptic Disorders	2006	21
Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures. Ida Niklson, Pascal Edrich, Peter Verdru PubMed NeuropsychologyPlacebo ResponseRefractory Partial-onset SeizuresPsychopharmacologyPharmacotherapy	2006	20
Identifying baseline characteristics of placebo responders <i>versus</i> nonresponders in randomized double‐blind trials of refractory partial‐onset seizures Ida Niklson, Pascal Edrich, Peter Verdru Epileptic Disorders NeuropsychologyPlacebo ResponsePsychotropic MedicationNeuromodulation TherapiesTreatment Effect	2006	18
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework Rima Izem, Emmanuel Zuber, Nadia Daizadeh, Therapeutic Innovation & Regulatory Science	2024	15

Page 1